Pharmacy strike today: Why chemists are protesting and what’s still open

A nationwide strike by chemists and pharmacists in India, orchestrated by the All India Organisation of Chemists and Druggists (AIOCD), has intensified the simmering conflict between traditional pharmaceutical retail and the rapidly expanding e-pharmacy sector. While participation has been notably mixed, leading to varied disruptions across states like Uttar Pradesh, Maharashtra, and Delhi, the core grievance remains the existential threat posed by online drug aggregators. Protesters cite concerns over perceived predatory pricing models that undercut traditional businesses, the potential for widespread prescription misuse due to lax verification, and the feared dilution of stringent drug quality control standards under the current, often ambiguous, regulatory framework governing digital platforms. This significant labor action is more than a localized dispute; it's a critical microcosm of the global digital transformation impacting established retail sectors, particularly evident in emerging economies like India. The AIOCD objections extend beyond competitive economics, targeting the government's perceived inertia in formulating robust regulations for e-pharmacies under the outdated Drug and Cosmetics Act, 1940. Furthermore, anxieties surround the ambitious Ayushman Bharat Digital Mission (ABDM), which, while aiming for a unified digital health ecosystem, inadvertently raises concerns among traditional pharmacists about patient data privacy, pharmaceutical ethics, and the potential erosion of their professional autonomy. The strike thus crystallizes a profound tension: balancing the imperative of innovation and accessibility in healthcare delivery with maintaining established public health safeguards and ensuring the economic viability of a vast, traditional labor force, exposing underlying issues of regulatory arbitrage and intensifying competitive pressures shaping the future of pharmaceutical distribution.